About this trial
The aim of this study is to prospectively evaluate the effects of pulsed and conventional radiofrequency ablation of the ganglion impar on pain, quality of life, and sleep quality in patients with refractory coccydynia, and to determine whether one treatment is superior to the other.
Eligibility criteria
Qualifiers
Age between 18 and 80 years.
Chronic pain in the coccygeal region lasting longer than 3 months, unresponsive to analgesics, anti-inflammatory drugs, and other conservative treatment methods.
Patients scheduled to undergo ganglion impar treatment with either conventional or pulsed radiofrequency ablation (RFA).
Disqualifiers
Incomplete medical records.
Loss to follow-up.
Technical failure during the block procedure.
Local infection, bleeding disorders, allergy to contrast agents, or history of spinal surgery.
Trial design
Treatments tested in this trial
- Pulsed Radiofrequency
- Conventional Radiofrequency